The DPO Centre

The European Commission’s announcement of its Digital Omnibus package proposal has set off one of the biggest privacy debates in years. On paper, it promises modernisation and simplification, but many are questioning what these potential changes could mean for the foundations of the GDPR. Is it an evolution or erosion of the gold standard that made it the global benchmark?

Join our expert panel for early reactions as they weigh up the pros and cons. They’ll challenge assumptions, discuss the details, and explore what matters most for organisations potentially facing another wave of regulatory change.

What we’ll discuss:

·      The biggest shifts proposed by the Digital Omnibus

·      Whether the EU AI Act is already out of date and what it means for AI projects

·      Does merging data laws simplify anything in practice?

·      Whether the GDPR can remain the global benchmark with rising pressure to ‘modernise’

The Digital Omnibus could redefine the direction of the GDPR and AI governance for years to come. Don’t miss this opportunity to join the debate and stay ahead of the potential changes. We’ll close with a live Q\&A, giving you the chance to ask questions and leave with a clearer view of what to monitor as the proposals move through the legislative process.


TERMINUS OR TURNING POINT? The Digital Omnibus and the future of GDPR and AI

The secondary use of health data is becoming one of the biggest drivers of innovation across clinical research. But as AI technology advances and EU and UK regulations evolve, CROs and sponsors need to think ahead about how trial data might be used, or reused, in the future. 

Join session moderator Ben Seretny, COO at The DPO Centre, alongside Lawrence Carter, DPO and Life Sciences Sector Lead, and Pippa Scotcher, DPO, for a forward-looking discussion on how AI and diverging governance frameworks are likely to impact the future of secondary data use and informed consent in clinical trials. 

You’ll learn: 

*   How EU and UK regulatory reforms are reshaping secondary use of data 
*   The growing role of AI in expanding the value and risk of health data reuse 
*   What this means for informed consent and site-level secondary data use 
*   Practical steps CROs and sponsors can take to prepare for evolving governance and ethical requirements 

This session will close with an open Q\&A discussion, with practical insights on how to stay compliant, future-ready and confident as AI redefines the boundaries of research data. 


DOUBLE BLIND: Secondary use of health data and AI in clinical trials 

I sistemi CRM sono strumenti fondamentali per massimizzare l’efficienza dei team di marketing e vendita. Tuttavia, gestire i dati dei sistemi CRM nel rispetto dei requisiti normativi del GDPR può risultare complesso. Conservare i dati troppo a lungo espone a rischi di non conformità, mentre eliminarli troppo presto significa perdere informazioni preziose. Gli esperti di protezione dei dati di The DPO Centre, insieme ad altri professionisti del settore, condivideranno soluzioni pratiche per bilanciare conformità normativa e sviluppo commerciale. Questa sessione è rilevante per responsabili della gestione dei dati nei software CRM.


TROPPO PRESTO O TROPPO TARDI? Conservazione dei dati nei CRM e conformità GDPR

Data Subject Access Requests (DSARs) in the Healthcare sector present unique challenges due to the sensitive nature of patient information. Responding to these requests requires not only an understanding of regulatory requirements but also a strategic approach to safeguarding personal data.

Join our specialist DPO, Dom Newton, and industry experts as they discuss the complexities of handling DSARs in Healthcare. From their many years of experience, you’ll gain insights into some of the practical strategies you can apply to reduce risk, ensure compliance with data protection laws, and protect patient data throughout the entire DSAR response process.

***

###### If you register to watch this webinar, your information will be used for the purpose of organising and communicating information about The DPO Centre Privacy Puzzle webinar series, which includes all the information provided in the registration sign-up form. We will also occasionally contact you about services and content that we feel are both relevant and of interest to you. 

###### *You can view The DPO Centre's Privacy notice *[*here*](https://www.dpocentre.com/privacy-notice/)*.*


STRICTLY CONFIDENTIAL: Reducing risk in health & social care DSAR responses

Quebec’s Law 25 represents a milestone for Canadian privacy legislation, strengthening privacy rights for individuals and updating organisational requirements. Our Canadian MD, Ray, will be joined by leading privacy professionals to take a closer look at this new legislation and provide essential information to help support your journey towards achieving and maintaining compliance. They will also explore the wider Canadian privacy landscape, including the current progress of Bill C-27 and whether it will pass before the next federal election.


LOOKING NORTH: How to navigate Quebec’s Law 25 and Canada’s evolving privacy landscape

Replays

TERMINUS OR TURNING POINT? The Digital Omnibus and the future of GDPR and AI

DOUBLE BLIND: Secondary use of health data and AI in clinical trials